Dexcom Opens €300m Athenry Plant, Targets 1,000 Jobs for EMEA Hub

Dexcom has flipped the switch on its €300 million manufacturing plant in Athenry, marking the San Diego company’s first European production hub after three years of construction, The Irish Times reported.

    The Bottom Line:

  • €300 million capital deployed; 500 staff already on site with a 1,000-employee target to serve the EMEA region.
  • Q3 revenue hit $1.34 billion, up 11% year-over-year, but international growth lagged at 5%, highlighting the supply-chain urgency.
  • Facility shifts sensor production closer to end users, cutting logistics risk for a franchise growing at a double-digit clip.

Supply Chain Logic Drives the Bet

Chief executive Jake Leach told The Irish Times the decision was straightforward: “The last thing we want to be doing is flying sensors all over the world. The idea is to put the plants close to where the people who are using the products are.”

Before Athenry, Dexcom’s only factories sat in the United States and the Asia-Pacific region, leaving the fast-growing Europe, Middle East and Africa corridor dependent on long-haul freight.

Leach said the company “felt as though it was time to pick a location in Europe to produce sensors for the region,” and the west of Ireland’s established medtech cluster — 16,000 specialists across Galway, Mayo and Roscommon — supplied the engineering depth the ramp required.

Revenue Momentum vs. International Drag

The numbers frame the urgency. Dexcom posted $1.34 billion (€1.22 billion) in third-quarter revenue, an 11% year-over-year increase, yet international revenue grew only 5%.

Leach has worked at the company for more than two decades and put it plainly: “We’ve been growing at a double-digit rate for many years and it really comes from more and more people using our technology to better manage their diabetes – with that, comes the need to produce more and more sensors.”

Us medtech company opens in athenry with jobs expected
Photo: khanlist.com

Talent Pipeline Already Flowing

Hiring started early. “We started hiring folks a while back, particularly some of the engineering teams, because we needed to train everybody on our technology,” Leach said. “We’ve actually had some of the Athenry engineering team visit our other plants around the world and spend some time with us in San Diego.”

The site sits near the M6 motorway and public transit, a deliberate choice Leach highlighted: “It’s a nice place for people to commute to.” Roles span engineering, HR, IT, operations and technician grades, with the headcount target set to double the current 500.

Cluster Effect in the West

The Irish Times noted the west of Ireland already employs 16,000 in medtech across three counties, a density that lowers onboarding risk for a precision manufacturing line.

Leach cited “an awareness within the west of Ireland of medical technologies; there’s a skill set there that we were really looking for.” That ecosystem, anchored by legacy players and research ties to University of Galway, turns a greenfield site into a scalable node rather than an isolated bet.

Community Anchor, Not Just a Factory

Leach framed the plant as a permanent stake: “The company’s goal was to be really be a member of the community.” Dexcom already sponsors Connacht Rugby’s home stadium in Galway city, a local visibility play that predates the factory opening. Dexcom invested about €300 million to open a manufacturing plant in Athenry, Co Galway, as its primary factory for Europe, the Middle East and Africa.

Founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel, Dexcom received FDA approval for its first continuous glucose monitoring system, the three-day STS, in 2006. The company went public in 2005 and joined the Nasdaq-100 index on April 20, 2020, replacing American Airlines Group. Before the Athenry facility opened, its only manufacturing sites were in Mesa, Arizona, and Batu Kawan, Malaysia.

“We’ve seen some really high-quality skill sets in the folks that we’ve hired and I’m really looking forward to seeing them grow,” Leach said.